{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T19:38:12Z","timestamp":1788464292806,"version":"build-2803163510"},"reference-count":42,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"unspecified","delay-in-days":28,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004332","name":"Seoul National University Hospital","doi-asserted-by":"publisher","award":["0620234330"],"award-info":[{"award-number":["0620234330"]}],"id":[{"id":"10.13039\/501100004332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002636","name":"Inje University","doi-asserted-by":"publisher","award":["20230146"],"award-info":[{"award-number":["20230146"]}],"id":[{"id":"10.13039\/501100002636","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014234","name":"Korean Society of Nephrology","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100014234","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Health & Welfare, Republic of Korea","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,1,12]]},"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Evidence related to the risk of kidney damage by proton pump inhibitor (PPI) initiation in patients with \u2018underlying\u2019 chronic kidney disease (CKD) remains scarce, although PPI use is generally associated with acute interstitial nephritis or incident CKD. We aimed to investigate the association between PPI initiation and the risk of adverse outcomes in patients with CKD in the absence of any deterministic indications for PPI usage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective observational study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Korea National Health Insurance Service database from 2009 to 2017.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>\n                      A retrospective cohort of new PPI and histamine H\n                      <jats:sub>2<\/jats:sub>\n                      -receptor antagonists (H2RA) users among people with CKD. Patients with a history of gastrointestinal bleeding or those who had an endoscopic or image-based upper gastrointestinal tract evaluation were excluded.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary and secondary outcome measures<\/jats:title>\n                    <jats:p>The study subjects were followed to ascertain clinical outcomes including mortality, end-stage kidney disease (ESKD), myocardial infarction and stroke. The HRs of outcomes were measured using a Cox regression model after adjusting for multiple variables. We applied an inverse probability of treatment weighting (IPTW) model to control for residual confounders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We included a total of 1038 PPI and 3090 H2RA users without deterministic indications for treatment. IPTW-weighted Cox regression analysis showed that PPI initiation was more significantly associated with a higher ESKD risk compared with that of H2RA initiation (adjusted HR 1.72 (95% CI 1.19 to 2.48)), whereas the risks of mortality or cardiovascular outcomes were similar between the two groups. In the subgroup analysis, multivariable Cox regression analysis showed that the association between PPI use and the progression to ESKD remained significant in non-diabetic and low estimated glomerular filtration rate (&lt;60\u2009mL\/min\/1.73\u2009m\n                      <jats:sup>2<\/jats:sup>\n                      ) groups (adjusted HR 1.72 (95% CI 1.19 to 2.48) and 1.63 (95% CI 1.09 to 2.43), respectively).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Initiation of PPI administration may not be recommended in patients with CKD without deterministic indication, as their usage was associated with a higher risk of ESKD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2023-078032","type":"journal-article","created":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T22:16:35Z","timestamp":1706566595000},"page":"e078032","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Non-indicated initiation of proton pump inhibitor and risk of adverse outcomes in patients with underlying chronic kidney disease: a nationwide, retrospective, cohort study"],"prefix":"10.1136","volume":"14","author":[{"given":"Seong Geun","family":"Kim","sequence":"first","affiliation":[{"name":"Inje University Sanggye Paik Hospital, Nowon-gu, Seoul, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Min","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Hospital, Jongno-gu, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2174-9726","authenticated-orcid":false,"given":"Kyungdo","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Statistics and Actuarial Science, Soongsil University, Dongjak-gu, Seoul, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwon-Wook","family":"Joo","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Hospital, Jongno-gu, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soojin","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Eulji University Uijeongbu Eulji Medical Center, Uijeongbu, Gyeonggi-do, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaerim","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semin","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, Gyeonggi-do, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyuk","family":"Huh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Inje University Busan Paik Hospital, Busan, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minsang","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Hospital, Jongno-gu, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunjeong","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Hospital, Jongno-gu, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Ki","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Hospital, Jongno-gu, Korea (the Republic of)"},{"name":"Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4221-2453","authenticated-orcid":false,"given":"Sehoon","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Hospital, Jongno-gu, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,1,29]]},"reference":[{"key":"2025121408154644000_14.1.e078032.1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.13766"},{"key":"2025121408154644000_14.1.e078032.2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04085.x"},{"key":"2025121408154644000_14.1.e078032.3","doi-asserted-by":"publisher","DOI":"10.3109\/02813432.2010.493315"},{"key":"2025121408154644000_14.1.e078032.4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.19.1690"},{"key":"2025121408154644000_14.1.e078032.5","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(86)90046-2"},{"key":"2025121408154644000_14.1.e078032.6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02454.x"},{"key":"2025121408154644000_14.1.e078032.7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39406.449456.BE"},{"key":"2025121408154644000_14.1.e078032.8","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcn035"},{"key":"2025121408154644000_14.1.e078032.9","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.1040876"},{"key":"2025121408154644000_14.1.e078032.10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128004","article-title":"Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis","volume":"10","author":"Lambert","year":"2015","journal-title":"PLoS One"},{"key":"2025121408154644000_14.1.e078032.11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.24.2947"},{"key":"2025121408154644000_14.1.e078032.12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.05345.x"},{"key":"2025121408154644000_14.1.e078032.13","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2014.04.027"},{"key":"2025121408154644000_14.1.e078032.14","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-14-1"},{"key":"2025121408154644000_14.1.e078032.15","doi-asserted-by":"publisher","DOI":"10.9778\/cmajo.20140074"},{"key":"2025121408154644000_14.1.e078032.16","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jamainternmed.2015.7193","article-title":"Proton pump inhibitor use and the risk of chronic kidney disease","volume":"176","author":"Lazarus","year":"2016","journal-title":"JAMA Intern Med"},{"key":"2025121408154644000_14.1.e078032.17","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12882-016-0325-4","article-title":"Proton pump inhibitors are associated with increased risk of development of chronic kidney disease","volume":"17","author":"Arora","year":"2016","journal-title":"BMC Nephrol"},{"key":"2025121408154644000_14.1.e078032.18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203878","article-title":"Chronic kidney disease (CKD) patients are exposed to more proton pump inhibitor (PPI) s compared to non-CKD patients","volume":"13","author":"Lee","year":"2018","journal-title":"PLoS One"},{"key":"2025121408154644000_14.1.e078032.19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39335.541782.AD"},{"key":"2025121408154644000_14.1.e078032.20","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyw253"},{"key":"2025121408154644000_14.1.e078032.21","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016640","article-title":"Cohort profile: the national health insurance service-national health screening cohort (NHIS-HEALS) in Korea","volume":"7","author":"Seong","year":"2017","journal-title":"BMJ Open"},{"key":"2025121408154644000_14.1.e078032.22","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2020121694"},{"key":"2025121408154644000_14.1.e078032.23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.034978"},{"key":"2025121408154644000_14.1.e078032.24","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-130-6-199903160-00002"},{"key":"2025121408154644000_14.1.e078032.25","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2019.07.012"},{"key":"2025121408154644000_14.1.e078032.26","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/jamainternmed.2015.7927","article-title":"Adverse effects associated with proton pump inhibitors","volume":"176","author":"Schoenfeld","year":"2016","journal-title":"JAMA Intern Med"},{"key":"2025121408154644000_14.1.e078032.27","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0000000000000406"},{"key":"2025121408154644000_14.1.e078032.28","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jamaneurol.2015.4791","article-title":"Association of proton pump inhibitors with risk of dementia: a Pharmacoepidemiological claims data analysis","volume":"73","author":"Gomm","year":"2016","journal-title":"JAMA Neurol"},{"key":"2025121408154644000_14.1.e078032.29","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-314605"},{"key":"2025121408154644000_14.1.e078032.30","doi-asserted-by":"publisher","DOI":"10.1586\/17512433.2013.811206"},{"key":"2025121408154644000_14.1.e078032.31","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-010-0141-0"},{"key":"2025121408154644000_14.1.e078032.32","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2011.199"},{"key":"2025121408154644000_14.1.e078032.33","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.74"},{"key":"2025121408154644000_14.1.e078032.34","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2010.71"},{"key":"2025121408154644000_14.1.e078032.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.12.021"},{"key":"2025121408154644000_14.1.e078032.36","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003363","article-title":"Association between the use of proton pump inhibitors and the risk of ESRD in renal diseases: a population-based, case-control study","volume":"95","author":"Peng","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2025121408154644000_14.1.e078032.37","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2015121377"},{"key":"2025121408154644000_14.1.e078032.38","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcz166"},{"key":"2025121408154644000_14.1.e078032.39","doi-asserted-by":"crossref","first-page":"462","DOI":"10.23736\/S2724-6051.21.04116-3","article-title":"Proton pump inhibitors use and risk of chronic kidney disease and end-stage renal disease","volume":"73","author":"Vengrus","year":"2021","journal-title":"Minerva Urol Nephrol"},{"key":"2025121408154644000_14.1.e078032.40","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-021-02449-0","article-title":"Proton-pump inhibitor vs. H2-receptor blocker use and overall risk of CKD progression","volume":"22","author":"Cholin","year":"2021","journal-title":"BMC Nephrol"},{"key":"2025121408154644000_14.1.e078032.41","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.l1580","article-title":"Estimates of all cause mortality and cause specific mortality associated with proton pump inhibitors among US veterans: cohort study","volume":"365","author":"Xie","year":"2019","journal-title":"BMJ"},{"key":"2025121408154644000_14.1.e078032.42","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/jcpt.13589","article-title":"Comparing safety of Proton\u2010Pump inhibitors versus H2\u2010Receptor antagonists in kidney transplant recipients: A systematic review and Meta\u2010Analysis","volume":"47","author":"Mohammadi","year":"2022","journal-title":"J Clin Pharm Ther"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-078032","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T16:15:53Z","timestamp":1765728953000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-078032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1,29]]},"published-print":{"date-parts":[[2024,1]]}},"alternative-id":["10.1136\/bmjopen-2023-078032"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-078032","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]}}}